Close Menu

NEW YORK (GenomeWeb) – Danaher today said that its wholly owned subsidiary DH Europe Finance has priced an offering of €850 million ($947 million) in senior notes.

DH Europe is offering €250 million principal amount of floating rate senior notes due 2022 at an offering price of 100.147 percent of the principal amount. It also is offering €600 million principal amount of 1.2 percent senior notes due 2027 at an offering price of 99.682 percent of the principal amount.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.